ENCORAFENIB
encorafenib 75 mg capsule, 42
ENCORAFENIB (12815L)
12815L
Manner of administration:Oral
Restriction 12484
Indication: Metastatic colorectal cancer
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 3 | Max qty units: 126 | # of repeats: 5 | DPMQ: $5,174.94 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Braftovi | |||||